Meeting
2023 ASCO Annual Meeting
Assessing racial differences in time to treatment escalation following androgen-deprivation therapy among veterans with prostate cancer.
Authors
Nadine Adriana Friedrich
Department of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles
Nadine Adriana Friedrich , Jessica Janes , Joshua Parrish , Amanda Marie De Hoedt , Janis Pruett , Mark Fallick , Raj Gandhi , Emily Zhu , Robert Morlock , Stephen J. Freedland
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer– Advanced/Hormone-Sensitive
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5078)
DOI
10.1200/JCO.2023.41.16_suppl.5078
Abstract #
5078
Poster Bd #
172
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Systemic and tumor-directed therapy for oligometastatic prostate cancer (SOLAR): A phase II trial for veterans with de novo oligometastatic prostate cancer.
First Author: Nicholas George Nickols
Poster
2023 ASCO Annual Meeting
Patient-level factors associated with the use of active surveillance: The Talking About Prostate Cancer Cohort.
First Author: Nita Mukand
Poster
2023 ASCO Genitourinary Cancers Symposium
Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): Individual patient data meta-analysis from the MARCAP Consortium.
First Author: Wee Loon Ong
Poster
2023 ASCO Genitourinary Cancers Symposium
The difference in serum testosterone recovery between Gn-RH Antagonist and LH-RH agonist among patients with prostate cancer treated with radiation therapy.
First Author: Akinori Takei